Jeff Yass’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,000
Closed -$365K – 14494
2026
Q2
$365K Sell
11,000
-25,600
-70% -$798K ﹤0.01% 10619
2026
Q1
$912K Buy
+36,600
New +$661K ﹤0.01% 8118
2025
Q1
– Sell
-1,700
Closed -$31.3K – 13420
2024
Q4
$31.3K Sell
1,700
-330
-16% -$10.1K ﹤0.01% 11831
2024
Q3
$70.2K Sell
2,030
-360
-15% -$14.1K ﹤0.01% 11238
2024
Q2
$70K Buy
+2,390
New +$94.5K ﹤0.01% 11244
2021
Q3
– Sell
-1,140
Closed -$212K – 13536
2021
Q2
$212K Sell
1,140
-400
-26% -$78.3K ﹤0.01% 11483
2021
Q1
$351K Sell
1,540
-1,640
-52% -$389K ﹤0.01% 10290
2020
Q4
$690K Buy
+3,180
New +$526K ﹤0.01% 7577

Other funds holding STRO

Jeff Yass's STRO Position: Q3 2026 in Review

Jeff Yass sold out of Sutro Biopharma (STRO) in Q3 2026, closing a stake of 8,426 shares — an estimated $280K sold.

Jeff Yass first reported a position in STRO in Q1 2021 and held it in 20 quarters. The position peaked at $2.11M in Q1 2026. 107 funds tracked by Wall St. Rank hold STRO as of Q3 2026.

  • Jeff Yass reported no remaining Sutro Biopharma position as of Q3 2026 after selling out during the quarter.
  • Jeff Yass sold 8,426 Sutro Biopharma shares in Q3 2026, an estimated $280K.
  • Jeff Yass first reported a position in Sutro Biopharma in Q1 2021 and held it in 20 quarters.
  • Jeff Yass's Sutro Biopharma position peaked at $2.11M in Q1 2026.
  • 107 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.